| Dr Jose J Arias Morales, MD | |
|
101 Ave San Patricio, Edif. Maramar Plaza Suite 1207, Guaynabo, PR 00968-2645 | |
| (787) 751-2509 | |
| (787) 781-5307 |
| Full Name | Dr Jose J Arias Morales |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 17 Years |
| Location | 101 Ave San Patricio, Guaynabo, Puerto Rico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306028865 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0600X | Psychiatry & Neurology - Clinical Neurophysiology | 17902 (Puerto Rico) | Secondary |
| 2084N0400X | Psychiatry & Neurology - Neurology | 17902 (Puerto Rico) | Primary |
| Entity Name | Recinto De Ciencias Medicas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316022312 PECOS PAC ID: 3678469962 Enrollment ID: O20040417000624 |
News Archive
Sequenom, Inc. and Lenetix Medical Screening Laboratory, Inc., a provider of rapid genetic screening and diagnostic testing for clinicians worldwide, today announced that they have entered into a collaboration and license agreement to develop and commercialize a proprietary non-invasive prenatal Rhesus D (RhD) incompatibility test based on Sequenom patent rights and RT PCR methodology.
With violence plaguing inner-city youth at epidemic rates, the report of a new study in the November issue of The Journal of the American College of Surgeons illustrated a research-based approach to confronting this national problem.
Point-of-Care Partners—a national health information technology strategy and management consulting firm—was recognized on September 21 for its role in helping Michigan attain the nation's second highest rate of ePrescribing in 2009. The commendation came as part of Surescripts' fifth annual Safe-Rx Awards, which are based on several factors including each state's overall ePrescribing volume.
Biologists at Tufts University School of Arts and Sciences have discovered that a change in membrane voltage in newly identified "instructor cells" can cause stem cells' descendants to trigger melanoma-like growth in pigment cells. The Tufts team also found that this metastatic transformation is due to changes in serotonin transport. The discovery could aid in the prevention and treatment of diseases like cancer and vitiligo as well as birth defects.
Researchers at the University of California in San Francisco have developed artificial intelligence (AI) technology that improves the effectiveness of brain imaging for the prediction of Alzheimer's disease.
› Verified 8 days ago
| Entity Name | Centro Medico Del Turabo Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710107883 PECOS PAC ID: 9335051952 Enrollment ID: O20080212000105 |
News Archive
Sequenom, Inc. and Lenetix Medical Screening Laboratory, Inc., a provider of rapid genetic screening and diagnostic testing for clinicians worldwide, today announced that they have entered into a collaboration and license agreement to develop and commercialize a proprietary non-invasive prenatal Rhesus D (RhD) incompatibility test based on Sequenom patent rights and RT PCR methodology.
With violence plaguing inner-city youth at epidemic rates, the report of a new study in the November issue of The Journal of the American College of Surgeons illustrated a research-based approach to confronting this national problem.
Point-of-Care Partners—a national health information technology strategy and management consulting firm—was recognized on September 21 for its role in helping Michigan attain the nation's second highest rate of ePrescribing in 2009. The commendation came as part of Surescripts' fifth annual Safe-Rx Awards, which are based on several factors including each state's overall ePrescribing volume.
Biologists at Tufts University School of Arts and Sciences have discovered that a change in membrane voltage in newly identified "instructor cells" can cause stem cells' descendants to trigger melanoma-like growth in pigment cells. The Tufts team also found that this metastatic transformation is due to changes in serotonin transport. The discovery could aid in the prevention and treatment of diseases like cancer and vitiligo as well as birth defects.
Researchers at the University of California in San Francisco have developed artificial intelligence (AI) technology that improves the effectiveness of brain imaging for the prediction of Alzheimer's disease.
› Verified 8 days ago
| Entity Name | Centro De Epilepsia Y Neurologia Avanzada Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306253729 PECOS PAC ID: 9931327236 Enrollment ID: O20140828001111 |
News Archive
Sequenom, Inc. and Lenetix Medical Screening Laboratory, Inc., a provider of rapid genetic screening and diagnostic testing for clinicians worldwide, today announced that they have entered into a collaboration and license agreement to develop and commercialize a proprietary non-invasive prenatal Rhesus D (RhD) incompatibility test based on Sequenom patent rights and RT PCR methodology.
With violence plaguing inner-city youth at epidemic rates, the report of a new study in the November issue of The Journal of the American College of Surgeons illustrated a research-based approach to confronting this national problem.
Point-of-Care Partners—a national health information technology strategy and management consulting firm—was recognized on September 21 for its role in helping Michigan attain the nation's second highest rate of ePrescribing in 2009. The commendation came as part of Surescripts' fifth annual Safe-Rx Awards, which are based on several factors including each state's overall ePrescribing volume.
Biologists at Tufts University School of Arts and Sciences have discovered that a change in membrane voltage in newly identified "instructor cells" can cause stem cells' descendants to trigger melanoma-like growth in pigment cells. The Tufts team also found that this metastatic transformation is due to changes in serotonin transport. The discovery could aid in the prevention and treatment of diseases like cancer and vitiligo as well as birth defects.
Researchers at the University of California in San Francisco have developed artificial intelligence (AI) technology that improves the effectiveness of brain imaging for the prediction of Alzheimer's disease.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jose J Arias Morales, MD 596 Calle Cesar Gonzalez Apt 1124, San Juan, PR 00918-4355 Ph: (787) 751-2509 | Dr Jose J Arias Morales, MD 101 Ave San Patricio, Edif. Maramar Plaza Suite 1207, Guaynabo, PR 00968-2645 Ph: (787) 751-2509 |
News Archive
Sequenom, Inc. and Lenetix Medical Screening Laboratory, Inc., a provider of rapid genetic screening and diagnostic testing for clinicians worldwide, today announced that they have entered into a collaboration and license agreement to develop and commercialize a proprietary non-invasive prenatal Rhesus D (RhD) incompatibility test based on Sequenom patent rights and RT PCR methodology.
With violence plaguing inner-city youth at epidemic rates, the report of a new study in the November issue of The Journal of the American College of Surgeons illustrated a research-based approach to confronting this national problem.
Point-of-Care Partners—a national health information technology strategy and management consulting firm—was recognized on September 21 for its role in helping Michigan attain the nation's second highest rate of ePrescribing in 2009. The commendation came as part of Surescripts' fifth annual Safe-Rx Awards, which are based on several factors including each state's overall ePrescribing volume.
Biologists at Tufts University School of Arts and Sciences have discovered that a change in membrane voltage in newly identified "instructor cells" can cause stem cells' descendants to trigger melanoma-like growth in pigment cells. The Tufts team also found that this metastatic transformation is due to changes in serotonin transport. The discovery could aid in the prevention and treatment of diseases like cancer and vitiligo as well as birth defects.
Researchers at the University of California in San Francisco have developed artificial intelligence (AI) technology that improves the effectiveness of brain imaging for the prediction of Alzheimer's disease.
› Verified 8 days ago
Vilma I Pagan, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 75 Calle Carazo, Guaynabo, PR 00969 Phone: 787-720-6690 Fax: 787-720-6690 | |
Dr. Wayca Rebeca Cespedes Gomez, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 107 Ave Ortegon Ste 208, Guaynabo, PR 00966 Phone: 787-230-2199 Fax: 787-230-2199 | |
Dr. Janice Rodriguez Hernandez, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: Maramar Plaza 1270, 101 Ave San Patricio, Guaynabo, PR 00968 Phone: 787-751-2509 Fax: 787-781-5307 | |
Selene Pena, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1 Ave. Albolote, Plaza Real Suite 310, Guaynabo, PR 00969 Phone: 787-300-5488 Fax: 787-300-5487 | |
Carmen Teresa Cancela, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: Urb. Valle Escondido, G-6 8th Street, Guaynabo, PR 00971 Phone: 787-283-7829 | |
Dr. Luis Joel Rivera, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 17 Calle 2 Ste 520, Guaynabo, PR 00968 Phone: 787-622-9797 | |
Franchesca Fiorito-torres, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 59 Ave Esmeralda, Urb. Munoz Rivera, Guaynabo, PR 00969 Phone: 787-720-3234 |